Patents by Inventor Takamune Takahashi

Takamune Takahashi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
    Patent number: 7176289
    Abstract: A method of modulating angiogenesis in a vertebrate subject, the method comprising administering to the vertebrate subject an ECRTP/DEP-1 activity-modulating amount of a composition, whereby an ECRTP/DEP-1 within the vertebrate subject is contacted by the composition; and modulating angiogenesis through the contacting of the ECRTP/DEP-1 with the composition. Optionally, the composition includes a monoclonal antibody which preferentially binds ECRTP/DEP-1. Methods for screening for modulators of ECRTP/DEP-1 are also disclosed.
    Type: Grant
    Filed: March 1, 2000
    Date of Patent: February 13, 2007
    Assignee: Vanderbilt University
    Inventors: Thomas O. Daniel, Takamune Takahashi, Raymond Mernaugh
  • Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
    Publication number: 20060198847
    Abstract: A method of modulating angiogenesis in a vertebrate subject, the method comprising administering to the vertebrate subject an ECRTP/DEP-1 activity-modulating amount of a composition, whereby an ECRTP/DEP-1 within the vertebrate subject is contacted by the composition; and modulating angiogenesis through the contacting of the ECRTP/DEP-1 with the composition. Optionally, the composition includes a monoclonal antibody which preferentially binds ECRTP/DEP-1. Methods for screening for modulators of ECRTP/DEP-1 are also disclosed.
    Type: Application
    Filed: May 2, 2006
    Publication date: September 7, 2006
    Inventors: Thomas Daniel, Takamune Takahashi, Raymond Mernaugh
  • Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
    Patent number: 6248327
    Abstract: A method of modulating angiogenesis in a vertebrate subject, the method comprising administering to the vertebrate subject an ECRTP/DEP-1 receptor activity-modulating amount of a composition, whereby an ECRTP/DEP-1 receptor within the vertebrate subject is contacted by the composition; and modulating angiogenesis through the contacting of the ECRTP/DEP-1 receptor with the composition. Optionally, the composition includes a monoclonal antibody which preferentially binds the ECRTP/DEP-1 receptor.
    Type: Grant
    Filed: September 11, 1998
    Date of Patent: June 19, 2001
    Assignee: Vanderbilt University
    Inventors: Thomas O. Daniel, Takamune Takahashi